Immunological Classification of Pancreatic Carcinomas to Identify Immune Index and Provide a Strategy for Patient Stratification

BACKGROUND: Cancer immunotherapy has produced significant positive clinical effects in a variety of tumor types. However, pancreatic ductal adenocarcinoma (PDAC) is widely considered to be a “cold” cancer with poor immunogenicity. Our aim is to determine the detailed immune features of PDAC to seek...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yi, Chen, Didi, Wang, Qiang, Xu, Yajing, Huang, Xiaowei, Haglund, Felix, Su, Huafang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801451/
https://www.ncbi.nlm.nih.gov/pubmed/35111149
http://dx.doi.org/10.3389/fimmu.2021.719105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801451/
https://www.ncbi.nlm.nih.gov/pubmed/35111149
http://dx.doi.org/10.3389/fimmu.2021.719105

Ejemplares similares